Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to 0.87.

  • Kiniksa Pharmaceuticals International's Asset Utilization Ratio rose 2442.57% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year increase of 2442.57%. This contributed to the annual value of 0.76 for FY2024, which is 3950.22% up from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Asset Utilization Ratio stood at 0.87 for Q3 2025, which was up 2442.57% from 0.84 recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Asset Utilization Ratio ranged from a high of 0.87 in Q3 2025 and a low of 0.02 during Q4 2022
  • In the last 5 years, Kiniksa Pharmaceuticals International's Asset Utilization Ratio had a median value of 0.53 in 2022 and averaged 0.46.
  • As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Asset Utilization Ratio crashed by 8629.86% in 2022, and later soared by 236226.1% in 2023.
  • Quarter analysis of 5 years shows Kiniksa Pharmaceuticals International's Asset Utilization Ratio stood at 0.16 in 2021, then plummeted by 86.3% to 0.02 in 2022, then surged by 2362.26% to 0.54 in 2023, then soared by 39.17% to 0.75 in 2024, then increased by 16.84% to 0.87 in 2025.
  • Its last three reported values are 0.87 in Q3 2025, 0.84 for Q2 2025, and 0.82 during Q1 2025.